These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15761997)

  • 1. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Chow AY
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15761997
    [No Abstract]   [Full Text] [Related]  

  • 2. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Moran AE; Cooper RS
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15758018
    [No Abstract]   [Full Text] [Related]  

  • 3. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Bellin EY
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15761996
    [No Abstract]   [Full Text] [Related]  

  • 4. Isosorbide dinitrate and hydralazine in blacks with heart failure.
    Eisenberger AB
    N Engl J Med; 2005 Mar; 352(10):1041-3; author reply 1041-3. PubMed ID: 15761995
    [No Abstract]   [Full Text] [Related]  

  • 5. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure.
    Taylor AL; Ziesche S; Yancy C; Carson P; D'Agostino R; Ferdinand K; Taylor M; Adams K; Sabolinski M; Worcel M; Cohn JN;
    N Engl J Med; 2004 Nov; 351(20):2049-57. PubMed ID: 15533851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Race and a heart drug.
    Peota C
    Minn Med; 2005 Mar; 88(3):11. PubMed ID: 15852585
    [No Abstract]   [Full Text] [Related]  

  • 7. BiDil for heart failure.
    Med Lett Drugs Ther; 2005 Sep; 47(1218):77-8. PubMed ID: 16186789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introduction: Facts and fictions: BiDil and the resurgence of racial medicine.
    Dorr GM; Jones DS
    J Law Med Ethics; 2008; 36(3):443-8. PubMed ID: 18840234
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA approves heart drug for black patients.
    Meadows M
    FDA Consum; 2005; 39(5):8-9. PubMed ID: 16419285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Color blind, or just plain blind?
    Czap A
    Altern Med Rev; 2005 Jun; 10(2):81-2. PubMed ID: 16032786
    [No Abstract]   [Full Text] [Related]  

  • 11. Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.
    Carson P; Ziesche S; Johnson G; Cohn JN
    J Card Fail; 1999 Sep; 5(3):178-87. PubMed ID: 10496190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Race, drugs, and heart failure.
    Aronow WS
    Geriatrics; 2005 Jul; 60(7):8-9. PubMed ID: 16026175
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel heart failure drug may offer options for you.
    Heart Advis; 2005 Sep; 8(9):2. PubMed ID: 16637097
    [No Abstract]   [Full Text] [Related]  

  • 14. BiDil (isosorbide dinitrate and hydralazine hydrochloride).
    Sica DA
    Congest Heart Fail; 2006; 12(2):110-1. PubMed ID: 16596047
    [No Abstract]   [Full Text] [Related]  

  • 15. Race-based therapeutics.
    Bloche MG
    N Engl J Med; 2004 Nov; 351(20):2035-7. PubMed ID: 15533852
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug success signals a new trend. A "race-based" medication is a step toward individualized care.
    Heart Advis; 2005 Apr; 8(4):4-5. PubMed ID: 16138392
    [No Abstract]   [Full Text] [Related]  

  • 17. Vasodilator therapy of hypertensive acute left ventricular failure: comparison of captopril-prazosin with hydralazine-isosorbide dinitrate.
    Adigun AQ; Ajayi OE; Sofowora GG; Ajayi AA
    Int J Cardiol; 1998 Nov; 67(1):81-6. PubMed ID: 9880204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitroso-redox balance in the cardiovascular system.
    Hare JM
    N Engl J Med; 2004 Nov; 351(20):2112-4. PubMed ID: 15533853
    [No Abstract]   [Full Text] [Related]  

  • 19. Current medical therapy for advanced heart failure.
    Gheorghiade M; Cody RJ; Francis GS; McKenna WJ; Young JB; Bonow RO
    Heart Lung; 2000; 29(1):16-32. PubMed ID: 10636954
    [No Abstract]   [Full Text] [Related]  

  • 20. Have we witnessed the rise and fall of race-specific drugs?
    Coons SJ
    Clin Ther; 2009 Mar; 31(3):620-2. PubMed ID: 19393852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.